DYADIC INTERNATIONAL, INC. Chart calendar Dyadic International, Inc.
e06db7a9f9b6a355.LzTrVZlCqZ_Q4pqxY2OzEQMJL0WRvU5JjVM_7VnpQIQ.WXXbGe4Dwfe507eJKgr-QEhbWxH_1jcF2AdLiTuLBMlYAaEX3BbbrJS0_Q~f0bd2af101fa1906daae8890e3b9cdde
Upcoming events on Dyadic International, Inc.
Past events on Dyadic International, Inc.
| 2024-03-31 | World Vaccine Congress |
| 2024-03-28 05:00 pm | Q4 2023 Earnings Call |
| 2024-03-28 04:00 pm | Q4 2023 Earnings Release |
| 2024-03-21 | Vaccine Innovation International Forum |
| 2024-03-20 | Future Food tech Innovation & Investment from Farm to Fork Conference |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-02-25 | BIO CEO & Investor Conference |
| 2024-02-01 08:45 am | Lytham Partners Investor Select Conference |
| 2024-01-30 | The Microcap Conference |
| 2024-01-07 06:15 pm | BFC Global Healthcare BD and Investment Conference |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-06 | Benchmark Company Discovery Conference |
| 2023-12-05 03:00 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-11-15 01:40 pm | Vaccines Summit |
| 2023-11-12 | BARDA Industry Day |
| 2023-11-08 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:00 pm | Q3 2023 Earnings Release |
| 2023-11-06 02:10 pm | International Vaccines Research & Development Conference |
| 2023-11-01 | Cultured Meat Symposium |
| 2023-10-18 05:45 am | World Vaccine Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,68 1,70 -1.11% | 1,60 1,90 -15.69% | 2,40 8,00 -69.95% | 2,93 3,65 -19.72% | 2,90 3,05 -4.96% | 4,20 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -11,1 -8,90 -25.17% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,28 -9,40 1.25% | -10,0 -10,1 0.74% | -14,7 -12,4 -18.77% | -10,2 -10,1 -0.65% | -8,23 -8,05 -2.23% | -23,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,30 -8,50 2.38% | -9,29 -9,50 2.17% | -13,1 -10,7 -22.73% | -9,74 -9,65 -0.88% | -6,80 -6,60 -2.96% | -22,7 |
|
Net income Million USD | Released Forecast Spread | -8,31 -8,50 2.26% | -9,33 -9,50 1.84% | -13,1 -10,7 -22.73% | -9,74 -9,65 -0.88% | -6,80 -6,60 -2.96% | -22,7 |
|
EPS USD | Released Forecast Spread | -0,31 -0,31 0% | -0,34 -0,35 2.86% | -0,47 -0,38 -23.68% | -0,34 -0,34 0% | -0,24 -0,23 -4.35% | -0,66 |
| Announcement Date | 30/03/20 | 30/03/21 | 29/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,31 0,80 -60.84% | 0,65 1,50 -56.77% | 0,66 2,40 -72.56% | 0,88 1,90 -53.71% | 0,74 1,45 -48.71% | 0,84 1,30 -35.6% | 0,40 1,20 -66.91% | 0,69 0,80 -14.18% | |
|
EBIT Million USD | Released Forecast Spread | -4,22 -1,95 -116.19% | -2,74 -3,90 29.62% | -3,32 -2,30 -44.26% | -1,86 -2,75 32.24% | -2,24 -2,15 -4.17% | -2,29 -1,50 -52.7% | -1,72 -1,70 -1.18% | -2,17 -1,95 -11.22% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,21 -1,85 -127.78% | -2,49 -3,90 36.11% | -3,29 -2,15 -52.93% | -1,81 -2,65 31.73% | -2,15 -2,05 -4.7% | -2,15 -1,40 -53.78% | -1,61 -1,65 2.17% | -2,07 -1,90 -9.04% | |
|
Net income Million USD | Released Forecast Spread | -4,21 -1,85 -127.78% | -2,49 -3,90 36.11% | -3,29 -2,15 -52.93% | -1,81 -2,65 31.73% | -2,15 -2,05 -4.7% | -0,96 | -2,15 -1,40 -53.78% | -1,61 -1,65 2.17% | -2,07 -1,90 -9.04% |
|
EPS USD | Released Forecast Spread | -0,15 -0,07 -130.77% | -0,09 -0,14 35.71% | -0,12 -0,08 -60% | -0,06 -0,10 36.84% | -0,07 -0,07 0% | -0,03 | -0,07 -0,05 -40% | -0,06 -0,06 0% | -0,08 -0,07 -23.08% |
| Announcement Date | 29/03/22 | 12/05/22 | 10/08/22 | 10/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/03/24 |
More events
Past sector events for Dyadic International, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
